Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression profile of <scp>COL2A1</scp> and the pseudogene <scp>SLC6A10P</scp> predicts tumor recurrence in high‐grade serous ovarian cancer

27 Aug 2015

Abstract excerpt

Tumor recurrence, following initial response to adjuvant chemotherapy, is a major problem in women with high-grade serous ovarian cancer (HGSOC). Microarray analysis of primary tumors has identified genes that may be useful in risk stratification/overall survival, but are of limited value in predicting the >70% rate for tumor recurrence. In this study, we performed RNA-Seq analysis of primary and recurrent HGSOC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Caveolin-1 and cellular processes
Share to Cell Adhesion Molecules Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26311224
DOI: 10.1002/ijc.29815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression profile of <scp>COL2A1</scp> and the pseudogene <scp>SLC6A10P</scp> predicts tumor recurrence in high‐grade serous ovarian cancerPMID 26311224Read ↗

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalSemantic proximity Read ↗

Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancerSemantic proximity Read ↗

Integrative Multi-Omics Analysis Reveals Molecular Signatures of Recurrence in Paired Primary and Recurrent High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression DatasetsSemantic proximity Read ↗

An Integrative Transcriptomic Analysis of a Stemness-Associated Gene Set on Ovarian Cancer RecurrenceSemantic proximity Read ↗

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patientsSemantic proximity Read ↗

Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell TumorsSemantic proximity Read ↗

Genomic alterations linked to recurrence risk in high-grade serous ovarian cancer revealed by deep targeted sequencing.Semantic proximity Read ↗

DNA methylation landscapes of matched primary and recurrent high grade serous ovarian cancers are preserved throughout disease progression and chemoresistanceSemantic proximity Read ↗

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapySemantic proximity Read ↗

Clinicopathological Predictors of Recurrence in Uterine Sarcomas – A Narrative ReviewSemantic proximity Read ↗

A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.